Related references
Note: Only part of the references are listed.Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells
Aixia Ren et al.
CANCER RESEARCH (2008)
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis
Inti Zlobec et al.
CLINICAL CANCER RESEARCH (2008)
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes
Inti Zlobec et al.
CLINICAL CANCER RESEARCH (2008)
Improved overall survival for patients with rectal cancer since 1990: The effects of TME surgery and pre-operative radiotherapy
Marcel den Dulk et al.
EUROPEAN JOURNAL OF CANCER (2008)
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
I. Zlobec et al.
GUT (2008)
cT3N0 rectal cancer: Potential overtreatment with Preoperative chemoradiotherapy is warranted
Jose G. Guillem et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype
Seung Sam Paik et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Newer pathologic assessment techniques for colorectal carcinoma
Roderick R. Turner et al.
CLINICAL CANCER RESEARCH (2007)
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells
Sara R. Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
T-cell activation in the intestinal mucosa
Dina Montufar-Solis et al.
IMMUNOLOGICAL REVIEWS (2007)
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers:: A potential role for dysregulation of the transforming growth factor-β pathway
Kristi Baker et al.
EUROPEAN JOURNAL OF CANCER (2007)
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
Fahd Al-Mulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells
Fuminori Teraishi et al.
CANCER RESEARCH (2006)
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012
M Mohiuddin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
EphB2 is a prognostic factor in colorectal cancer
AM Jubb et al.
CLINICAL CANCER RESEARCH (2005)
RHAAW expression and isoform balance predict aggressive disease and poor survival in multiple myeloma
CA Maxwell et al.
BLOOD (2004)
Tissue microarrays in drug discovery
G Sauter et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
